ClinicalTrials.gg
Not yet recruitingNCT06984770Family CaresUpdated May 22, 2025

The Family Cares Trial

An interventional study of Virtual peer support group intervention and Caregiver Support intervention in Family Engagement, Critical Care, Intensive Care and Patient and Family Engagement, sponsored by Lady Davis Institute. Not yet recruiting at 2 sites in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-22.

Sponsored by Lady Davis Institute · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this pilot study is to learn if virtual peer support groups and strengths-based skills training can help family caregivers of ICU survivors providing ongoing support to ICU survivors after hospital discharge. The main question it aims to answer is:

  • Are virtual peer support groups and/or strengths-based skills support feasible and acceptable for family caregivers of ICU survivors? Researchers will compare the intervention group (virtual peer support groups or strengths-based skills training) to the control group (no intervention) to see if the interventions improve caregiver outcomes and assess feasibility and acceptability.

Participants will:

  • Participate in either virtual peer support groups or strengths-based skills training sessions (if assigned to the intervention arm).
  • Provide feedback on the feasibility and acceptability of the interventions (if assigned to the intervention arm).
  • Complete surveys and follow-up questionnaires (either online or by phone) to measure outcomes.
02

Conditions studied

  • Family Engagement
  • Critical Care, Intensive Care
  • Patient and Family Engagement
  • Health Care Delivery
  • Family-centered Care
  • Pilot Study
  • Caregiver
  • Caregiver Burden
  • Family Caregivers

Browse trials for

Keywords

  • Patient- and Family-Centered Care
  • Family Engagement
  • Critical Care
  • Intensive Care Unit
  • Person-Centered Care
  • Delivery of Health Care
  • Post-ICU
  • Caregivers
  • Family Caregiver
03

In context

Caregiver Burden

500 studies on the registry are indexed under Caregiver Burden; 164 are open to participants now.

This study's planned enrollment of 60 is below the median of 71 across 402 interventional studies indexed under Caregiver Burden.

Browse Caregiver Burden studies →

Lead sponsor

Lady Davis Institute is the lead sponsor of 46 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (1) Family member of a person admitted to an ICU for >48 hours and survived to hospital discharge. "Family" is anyone with a biological, legal, or emotional relationship with the patient and whom the patient wants involved in their care
  • (2) Planned or current part or full-time caregiver of the ICU survivor
  • (3) Age ≥ 18 years
  • (4) Within 6 months of ICU survivor's hospital discharge.

Exclusion criteria

Exclusion Criteria:

  • (1) Another family member participating in the study
  • (2) Inability to communicate in English or French.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Control Group: Resources only

    Participants will be given a list of resources for emotional or psychological distress.

    Other: Resources

  • Experimental
    Intervention Group

    Participants assigned to the intervention group will be permitted to choose which strategy they wish to participate in. This innovative person-centered approach will ensure that family caregivers get the type of support that they want and are not arbitrarily assigned to a strategy that they are not motivated to pursue, resulting in a pragmatic, real-world approach to choice of strategy. Participants will have the choice of two strategies: 'Virtual peer support group' or 'Caregiver Support'.

    Behavioral: Virtual peer support group intervention · Behavioral: Caregiver Support intervention · Other: Resources

Interventions

  • BehavioralVirtual peer support group intervention

    The virtual peer support group aims to improve emotional well-being, reduce isolation, and help caregivers cope by offering a safe space to share experiences and receive support from others facing similar caregiving demands.

  • BehavioralCaregiver Support intervention

    The caregiver support intervention is a personalized program designed to improve quality of life, reduce fatigue and caregiver burden, and build resilience.

  • OtherResources

    Participants will be given a list of resources to contact in case of emotional or psychological distress.

06

What researchers measure

Primary outcomes

  1. Caregiver Burden - The Zarit Burden Interview-12 (ZBI-12) - 3 months

    A 12-item self-report tool that has been validated for measuring the level of caregiver burden related to care provision. Each item in the ZBI-12 is scored on a five-point Likert scale from 0 to 4 (0=never to 4=nearly always). Summed scores range from 0-48, with greater scores representing greater feelings of burden.

    Time frame: 3 months post-enrollment or post intervention initiation

Secondary outcomes

  1. Caregiver Burden - The Zarit Burden Interview-12 (ZBI-12) - 6 months

    A 12-item self-report tool that has been validated for measuring the level of caregiver burden related to care provision. Each item in the ZBI-12 is scored on a five-point Likert scale from 0 to 4 (0=never to 4=nearly always). Summed scores range from 0-48, with greater scores representing greater feelings of burden.

    Time frame: 6 months post-enrollment or post intervention initiation

  2. Multidimensional Scale of Perceived Social Support (MSPSS) - 3 months

    A 12-item self-report tool that has been validated for measuring perceived social support from family, friends and significant others. Each item is scored on a likert scale from 1-7, where 1= Very strongly disagree, and 7= very strongly agree. Total scores range from 12 to 84, where a score of 12-35 could be considered low support; a score of 33 to 60 could be considered moderate support; a score from 61 to 84 could be considered high support.

    Time frame: 3 months post-enrollment or post intervention initiation

  3. Multidimensional Scale of Perceived Social Support (MSPSS) - 6 months

    A 12-item self-report tool that has been validated for measuring perceived social support from family, friends and significant others. Each item is scored on a likert scale from 1-7, where 1= Very strongly disagree, and 7= very strongly agree. Total scores range from 12 to 84, where a score of 12-35 could be considered low support; a score of 33 to 60 could be considered moderate support; a score from 61 to 84 could be considered high support.

    Time frame: 6 months post-enrollment or post intervention initiation

  4. Patient Health Questionnaire-9 (PHQ-9) - 3 months

    A 9-item self-reported tool to quantify depression symptoms and monitor severity. Each item is scored using a 4-point Likert scale ranging from 0-3 (not at all=0, several days=1, more than half the days=2, and nearly every day=3). The total score can range from 0 to 27, where a total score of 0-4 indicates minimal to no depression, 5-9 indicates mild depression, 10-14 indicates moderate depression, 15-19 indicates moderately severe depression, and 20-27 indicates severe depression.

    Time frame: 3 months post-enrollment or post intervention initiation

  5. Patient Health Questionnaire-9 (PHQ-9) - 6 months

    A 9-item self-reported tool to quantify depression symptoms and monitor severity. Each item is scored using a 4-point Likert scale ranging from 0-3 (not at all=0, several days=1, more than half the days=2, and nearly every day=3). The total score can range from 0 to 27, where a total score of 0-4 indicates minimal to no depression, 5-9 indicates mild depression, 10-14 indicates moderate depression, 15-19 indicates moderately severe depression, and 20-27 indicates severe depression.

    Time frame: 6 months post-enrollment or post intervention initiation

  6. Post-traumatic stress (IES-Revised) - 3 months

    The IES-Revised is a 22-item questionnaire that has been validated and is widely used for measuring post-traumatic stress symptoms and yields a total score ranging from 0 to 88 and subscale scores for the Intrusion, Avoidance, and Hyperarousal subscales. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). High scores indicate greater severity of PTSD.

    Time frame: 3 months post-enrollment or post intervention initiation

  7. Post-traumatic stress (IES-Revised) - 6 months

    The IES-Revised is a 22-item questionnaire that has been validated and is widely used for measuring post-traumatic stress symptoms and yields a total score ranging from 0 to 88 and subscale scores for the Intrusion, Avoidance, and Hyperarousal subscales. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). High scores indicate greater severity of PTSD.

    Time frame: 6 months post-enrollment or post intervention initiation

  8. Insomnia Severity Index (ISI) - 3 months

    A 7-item self-report questionnaire that has been validated for measuring the nature, severity, and impact of insomnia. Responses on each item can range from 0 to 4, where higher scores indicate more acute symptoms of insomnia. Total score ranges from 0-28, and can be interpreted as follows: a total score of 0-7 indicates "no clinically significant insomnia," 8-14 indicates "subthreshold insomnia," 15-21 indicates "clinical insomnia (moderate severity)," and 22-28 indicates "clinical insomnia (severe).

    Time frame: 3 months post-enrollment or post intervention initiation

  9. Insomnia Severity Index (ISI) - 6 months

    A 7-item self-report questionnaire that has been validated for measuring the nature, severity, and impact of insomnia. Responses on each item can range from 0 to 4, where higher scores indicate more acute symptoms of insomnia. Total score ranges from 0-28, and can be interpreted as follows: a total score of 0-7 indicates "no clinically significant insomnia," 8-14 indicates "subthreshold insomnia," 15-21 indicates "clinical insomnia (moderate severity)," and 22-28 indicates "clinical insomnia (severe).

    Time frame: 6 months post-enrollment or post intervention initiation

  10. Quality of life (EuroQOL-5D-5L score) - 3 months

    The EuroQOL-5D-5L is a 5-item questionnaire that has been validated and is widely used for measuring health-related quality of life. Each dimension has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). The scores are combined to generate a single index value for overall health status. EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state

    Time frame: 3 months post-enrollment or post intervention initiation

  11. Quality of life (EuroQOL-5D-5L score) - 6 months

    The EuroQOL-5D-5L is a 5-item questionnaire that has been validated and is widely used for measuring health-related quality of life. Each dimension has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). The scores are combined to generate a single index value for overall health status. EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state

    Time frame: 6 months post-enrollment or post intervention initiation

  12. Connor-Davidson Resilience Scale-10 (CD-RISC 10) - 3 months

    A 10-item self-report tool that has been validated for measuring resilience. Each item is scored on a 5-point Likert scale (0 = "not true at all" to 4 = "true nearly all the time"). The total score ranges from 0 to 40, with higher scores indicating greater resilience.

    Time frame: 3 months post-enrollment or post intervention initiation

  13. Connor-Davidson Resilience Scale-10 (CD-RISC 10) - 6 months

    A 10-item self-report tool that has been validated for measuring resilience. Each item is scored on a 5-point Likert scale (0 = "not true at all" to 4 = "true nearly all the time"). The total score ranges from 0 to 40, with higher scores indicating greater resilience.

    Time frame: 6 months post-enrollment or post intervention initiation

Other outcomes

  1. FAM-Activate (FAM-A)

    The FAM-Activate (FAM-A) tool is a self-administered 4-item questionnaire that assesses an individual's current activation. FAM-A uses a five-point Likert scale ranging from 1 (strongly agree) to 5 (strongly disagree), and scale results are changed to a 0-100 scoring system, with higher scores indicating greater activation. Activation refers to the knowledge, skills, and confidence of a family member.

    Time frame: completed at enrolment in the study

  2. FAMily Engagement (FAME)

    The FAMily Engagement (FAME) tool is a self-administered 12-item questionnaire that assesses an individual's current engagement practice. FAME uses a five-point Likert scale ranging from 1 (strongly agree) to 5 (strongly disagree), and scale results are changed to a 0-100 scoring system, with higher scores indicating greater engagement in care. The following subdomains are evaluated: engagement perception, family presence, communication, education, decision-making, care contribution, and family needs. FAME includes the following engagement domains: family presence, family needs, communication and education, decision making, and direct care. FAME also captures the following family-centered care principles: dignity and respect, information sharing, participation, and collaboration.

    Time frame: completed at enrolment in the study

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06984770
Lead sponsor
Lady Davis Institute
Responsible party
Michael Goldfarb (Attending Staff, Division of Cardiology, Lady Davis Institute) — Principal investigator
First posted
May 22, 2025
Start date
Aug 2025 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
May 22, 2025

Study contacts

Jillian Kifell, MSc
Contact
jillian.kifell.ccomtl@ssss.gouv.qc.ca
5143408222 ext. 25806
Michael J Goldfarb, MD, MSc
principal investigator · Lady Davis Institute, McGill University, Jewish General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion